Document is current
Any future updates will be listed below
-
Authors
de Lima, Marcos https://orcid.org/0000-0002-8568-4522
Marks, David I.
- License Information
-
More Information
Article History
Accepted: 29 January 2025
First Online: 20 March 2025
Declarations
:
: This podcast was sponsored by Pfizer. No funding was provided for the authoring of this review. The authors received no honoria related to the development of this publication. Medical writing support was provided by Sarah Moore, MSc, of Engage Scientific Soloutions and funded by Pfizer.
: Marcos de Lima reports a consulting or advisory role at BMS, Autolus, and Pfizer; research funding from Miltenyi and Priothera; and he is on the data monitoring committee at AbbVie and Novartis. David I. Marks reports consulting at Pfizer and Nexcella.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: The authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship of this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
: M.d.L. and D.M. made substantial contributions to the concept/design of the manuscript, critically reviewed and revised the manuscript drafts, and provided final approval of the manuscript and enhanced content as submitted.
